ABSTRACT:
The present invention relates to a process synthetic process for preparing the side-chain precursor l-(mercaptomethyl)cyclopropancacctic acid, Which is useful in the synthesis of leukotriene receptor antagonist such as Montelukast and salts thereof.
Preferably the present invention relates to a process ...
Documents
Form DIR-12-24052019_signed
Evidence of cessation;-25042019
Notice of resignation;-25042019
List of share holders, debenture holders;-23012019
Directors report as per section 134(3)-23012019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-23012019
Form MGT-7-23012019_signed
Form AOC-4-23012019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-24112017
Directors report as per section 134(3)-24112017
List of share holders, debenture holders;-24112017
Form AOC-4-24112017_signed
Form MGT-7-24112017_signed
Form DIR-12-03062017_signed
Optional Attachment-(1)-02062017
Letter of appointment;-02062017
Declaration of the appointee director, Managing director, in Form No. DIR-2;-02062017
Directors report as per section 134(3)-19112016
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-19112016
Form AOC-4-19112016_signed
List of share holders, debenture holders;-18112016